These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 38071104

  • 1. Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh.
    Malaker R, Hasanuzzaman M, Hooda Y, Rahman H, Chandra Das R, Kanon N, Saha S, Tanmoy AM, Ranjan Chakraborty S, Saha S, Islam M, Darmstadt GL, Baqui AH, Sathosam M, El-Arifeen S, Whitney CG, Saha SK.
    Vaccine; 2024 Jan 12; 42(2):255-262. PubMed ID: 38071104
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
    Savulescu C, Krizova P, Valentiner-Branth P, Ladhani S, Rinta-Kokko H, Levy C, Mereckiene J, Knol M, Winje BA, Ciruela P, de Miguel S, Guevara M, MacDonald L, Kozakova J, Slotved HC, Fry NK, Pekka Nuorti J, Danis K, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Sanz JC, Castilla J, Smith A, Colzani E, Pastore Celentano L, Hanquet G, SpIDnet VE study group.
    Vaccine; 2022 Jun 23; 40(29):3963-3974. PubMed ID: 35637067
    [Abstract] [Full Text] [Related]

  • 3. Long-term surveillance of invasive pneumococcal disease: The impact of 10-valent pneumococcal conjugate vaccine in the metropolitan region of Salvador, Brazil.
    Reis JN, Azevedo J, de Oliveira AML, Menezes APO, Pedrosa M, Dos Santos MS, Ribeiro LC, Freitas HF, Gouveia EL, Teles MB, Carvalho MDG, Reis MG, Nascimento-Carvalho C, Verani JR.
    Vaccine; 2024 Jan 25; 42(3):591-597. PubMed ID: 38184393
    [Abstract] [Full Text] [Related]

  • 4. Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland.
    Nuorti JP, Rinta-Kokko H, Toropainen M, Siira L, Nohynek H, Palmu AA.
    Vaccine; 2022 Sep 29; 40(41):5950-5958. PubMed ID: 36075797
    [Abstract] [Full Text] [Related]

  • 5. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
    Rinta-Kokko H, Palmu AA, Auranen K, Nuorti JP, Toropainen M, Siira L, Virtanen MJ, Nohynek H, Jokinen J.
    Vaccine; 2018 Apr 05; 36(15):1934-1940. PubMed ID: 29526371
    [Abstract] [Full Text] [Related]

  • 6. Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands.
    Peckeu L, van der Ende A, de Melker HE, Sanders EAM, Knol MJ.
    Vaccine; 2021 Jan 08; 39(2):431-437. PubMed ID: 33243632
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study.
    Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, Santos JB, de Moraes JC, Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study Group.
    Lancet Respir Med; 2014 Jun 08; 2(6):464-71. PubMed ID: 24726406
    [Abstract] [Full Text] [Related]

  • 8. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Brandileone MC, Almeida SCG, Minamisava R, Andrade AL.
    Vaccine; 2018 May 03; 36(19):2559-2566. PubMed ID: 29650385
    [Abstract] [Full Text] [Related]

  • 9. Invasive disease potential of Streptococcus pneumoniae serotypes before and after 10-valent pneumococcal conjugate vaccine introduction in a rural area, southern Mozambique.
    Massora S, Lessa FC, Moiane B, Pimenta FC, Mucavele H, Chaúque A, Cossa A, Verani JR, Tembe N, da Gloria Carvalho M, Muñoz-Almagro C, Sigaúque B.
    Vaccine; 2019 Dec 03; 37(51):7470-7477. PubMed ID: 31575493
    [Abstract] [Full Text] [Related]

  • 10. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
    Hammitt LL, Etyang AO, Morpeth SC, Ojal J, Mutuku A, Mturi N, Moisi JC, Adetifa IM, Karani A, Akech DO, Otiende M, Bwanaali T, Wafula J, Mataza C, Mumbo E, Tabu C, Knoll MD, Bauni E, Marsh K, Williams TN, Kamau T, Sharif SK, Levine OS, Scott JAG.
    Lancet; 2019 May 25; 393(10186):2146-2154. PubMed ID: 31000194
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland.
    Rinta-Kokko H, Auranen K, Toropainen M, Nuorti JP, Nohynek H, Siira L, Palmu AA.
    Vaccine; 2020 Feb 05; 38(6):1559-1564. PubMed ID: 31791813
    [Abstract] [Full Text] [Related]

  • 12. Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.
    Jokinen J, Rinta-Kokko H, Siira L, Palmu AA, Virtanen MJ, Nohynek H, Virolainen-Julkunen A, Toropainen M, Nuorti JP.
    PLoS One; 2015 Feb 05; 10(3):e0120290. PubMed ID: 25781031
    [Abstract] [Full Text] [Related]

  • 13. A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children.
    Mungall BA, Hoet B, Nieto Guevara J, Soumahoro L.
    Expert Rev Vaccines; 2022 Feb 05; 21(2):201-214. PubMed ID: 34882050
    [Abstract] [Full Text] [Related]

  • 14. Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly.
    van Werkhoven CH, Hollingsworth RC, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Sanders EA, Bonten MJ.
    Vaccine; 2016 Jun 14; 34(28):3275-82. PubMed ID: 27171754
    [Abstract] [Full Text] [Related]

  • 15. Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study.
    Shrestha S, Gurung M, Amatya P, Bijukchhe S, Bose AS, Carter MJ, Gautam MC, Gurung S, Hinds J, Kandasamy R, Kelly S, Khadka B, Maskey P, Mujadidi YF, O'Reilly PJ, Pokhrel B, Pradhan R, Shah GP, Shrestha S, Wahl B, O'Brien KL, Knoll MD, Murdoch DR, Kelly DF, Thorson S, Voysey M, Pollard AJ, PneumoNepal study group.
    Lancet Glob Health; 2022 Oct 14; 10(10):e1494-e1504. PubMed ID: 36113533
    [Abstract] [Full Text] [Related]

  • 16. Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.
    Richter L, Schmid D, Kanitz EE, Zwazl I, Pöllabauer E, Jasinska J, Burgmann H, Kundi M, Wiedermann U.
    PLoS One; 2019 Oct 14; 14(1):e0210081. PubMed ID: 30629620
    [Abstract] [Full Text] [Related]

  • 17. Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
    Baqui AH, Koffi AK, McCollum ED, Roy AD, Chowdhury NH, Rafiqullah I, Ahmed ZB, Mahmud A, Begum N, Ahmed S, Khanam R, Harrison M, Simmons N, Hossen S, Islam M, Quaiyum A, Checkley W, Santosham M, Moulton LH, Saha SK, Projahnmo Study Group in Bangladesh.
    Vaccine; 2021 Sep 24; 39(40):5794-5801. PubMed ID: 34465471
    [Abstract] [Full Text] [Related]

  • 18. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis.
    Silaba M, Ooko M, Bottomley C, Sande J, Benamore R, Park K, Ignas J, Maitland K, Mturi N, Makumi A, Otiende M, Kagwanja S, Safari S, Ochola V, Bwanaali T, Bauni E, Gleeson F, Deloria Knoll M, Adetifa I, Marsh K, Williams TN, Kamau T, Sharif S, Levine OS, Hammitt LL, Scott JAG.
    Lancet Glob Health; 2019 Mar 24; 7(3):e337-e346. PubMed ID: 30784634
    [Abstract] [Full Text] [Related]

  • 19. Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
    Kozakova J, Krizova P, Maly M.
    PLoS One; 2021 Mar 24; 16(2):e0247862. PubMed ID: 33635933
    [Abstract] [Full Text] [Related]

  • 20. Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics.
    Palmborg A, Skovdal M, Molden T, Åhman H, Chen L, Banefelt J.
    PLoS One; 2023 Mar 24; 18(6):e0287378. PubMed ID: 37363884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.